Constanze Schweikert

Constanze Schweikert is a Director at AstraZeneca, where they focus on Quality and Compliance across the Medical Affairs organization in the USA and Latin America. With extensive experience in clinical development, they have led significant studies, including a pivotal phase III trial for a high-priority cancer treatment. Previously, Constanze served in various roles within AstraZeneca, including Clinical Development Manager and Clinical Research Associate, managing multiple oncology and neuroscience studies. They hold a Master of Public Health from Lakehead University and are pursuing a Bachelor of Science in Bioinformatics from Universität Ulm.